Mirae Asset Global Etfs Holdings Ltd. Harmony Biosciences Holdings, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 23,971 shares of HRMY stock, worth $653,928. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,971
Previous 22,651
5.83%
Holding current value
$653,928
Previous $751,000
0.8%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding HRMY
# of Institutions
289Shares Held
46.3MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$181 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$159 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$139 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$44.4 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$43.2 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.61B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...